|
ALS2CR8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.223600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.600400E-02 |
| Normal-vs-Stage2 |
6.650600E-01 |
| Normal-vs-Stage3 |
9.80179999999775E-05 |
| Normal-vs-Stage4 |
1.303810E-03 |
| Stage1-vs-Stage2 |
5.992400E-01 |
| Stage1-vs-Stage3 |
1.904990E-03 |
| Stage1-vs-Stage4 |
7.180400E-03 |
| Stage2-vs-Stage3 |
4.724000E-02 |
| Stage2-vs-Stage4 |
3.914000E-02 |
| Stage3-vs-Stage4 |
8.024200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.296200E-02 |
| Normal-vs-AfricanAmerican |
2.068600E-01 |
| Normal-vs-Asian |
4.219700E-03 |
| Caucasian-vs-AfricanAmerican |
5.600800E-01 |
| Caucasian-vs-Asian |
1.202790E-01 |
| AfricanAmerican-vs-Asian |
9.819900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.551700E-02 |
| Normal-vs-Female |
2.758400E-01 |
| Male-vs-Female |
3.306600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.845750E-02 |
| Normal-vs-Extreme_Weight |
1.620470E-02 |
| Normal-vs-Obese |
2.117200E-01 |
| Normal-vs-Extreme_Obese |
4.453600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.676000E-01 |
| Normal_Weight-vs-Obese |
2.609200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.985600E-01 |
| Extreme_Weight-vs-Obese |
2.817000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.085400E-01 |
| Obese-vs-Extreme_Obese |
9.338000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.370100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.587800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.669600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.321880E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.113900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.865000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.397200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.945800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.026560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.705600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.284800E-01 |
| Normal-VS-Type2 PRCC |
1.82400000003913E-06 |
| Normal-VS-KIRP CIMP |
5.800900E-04 |
| Normal-VS-Unclassified PRCC |
5.593000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.27329999666648E-08 |
| Type1 PRCC-VS-KIRP CIMP |
6.06109999999882E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.051400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.394200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.412260E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.239900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.76340000000486E-05 |
| Normal-vs-N1 |
4.568700E-04 |
| Normal-vs-N2 |
5.39099986873737E-10 |
| N0-vs-N1 |
7.159200E-01 |
| N0-vs-N2 |
2.66260000003626E-06 |
| N1-vs-N2 |
3.401200E-03 |
|
|
